Skip to main content
Premium Trial:

Request an Annual Quote

Lexicon, Gene Network Sciences, OpGen, Illumina, add to board of directors; Cambrex Names John Leone President and CEO; and others

NEW YORK, Aug. 4 (GenomeWeb News) - Lexicon Genetics announced this week that Clayton Rose has been elected to its board of directors and will join the board's audit committee.


Rose is currently a private investor and an adjunct professor at Columbia University's Graduate School of Business and New York University's Stern School of Business. He has headed each of the global investment banking and global equities divisions of JP Morgan & Co, and was a member of the firm's executive committee. Rose holds an AB and MBA from the Universityof Chicago, and is currently pursuing a PhD in sociology from the Universityof Pennsylvania.


Gene Network Sciences said this week that Raymond Salemme has joined the company's board of directors, and James Watson has been named chief operating officer and chief financial officer of the Ithaca, NY-based company.


Salemme is CEO of biotech company Linguagen, and founder and former CEO of 3-Dimensional Pharmaceuticals. He has also held scientific and executive posts at Sterling Winthrop Pharmaceuticals, DuPont Merck Pharmaceuticals, and Genex, GNS said. Salemme has also served as a professor of biochemistry at the Universityof Arizona.


Watson recently co-founded Pathlight Technology, and served as the company's COO and CFO. Prior to this, Watson was president, COO, and CFO of I.I. Holdings and Ironics, and president of Ithaca Intersystems.


OpGen has appointed James Ogle and Thomas Pyle to its board of directors, the company said this week.


Ogle is currently the CEO of INC Research. Prior to this, he was president and chief operating officer of Quintiles Product Development Group. He has also served as president of Quintiles Americas, president and CEO of BRI International, and president of ERC BioServices. Ogle served for 20 years in the Unites States Army, achieving the rank of lieutenant colonel.


Pyle is chairman of The Pyle Group, a financial services and investment company. Prior to this, he served as chairman, CEO, president, and principal owner of Rayovac. He earned a bachelor's degree from La SalleUniversityand an MBA from the University of Wisconsin-Madison.


Illumina has named Karin Eastham to its board of directors, the company said this week.


Eastham is currently the executive vice president, chief operating officer, and a member of the board of trustees of the Burnham Institute. Prior to this, Eastham was senior vice president and chief financial officer of Diversa. She has also held similar positions with CombiChem, Cytel, and Boehringer Mannheim, Illumina said. She received BS and MBA degrees from IndianaUniversity.


John Leone will be the new president and CEO of Cambrex, effective August 23, the company said this week.


Leone joins Cambrex from Aventis, where he most recently served as president of its dermatology division, and prior to that, as senior vice president and chief operating officer of US commercial operations. He has a BS in engineering from the US Military Academy at West Point, and an MBA from the Universityof Colorado.


Leone replaces James Mack, who served as president and CEO since 1995. Mack, who was appointed chairman of the board of directors in 1999, will remain in this position until April 2005.


Cambrex also said that its board of directors has appointed Gary Mossman to the position of executive vice president and chief operating officer. Mossman joined Cambrex in 2003, and served as president and CEO of the pharma and biopharmaceuticals businesses.


Serologicals has named Robert Brown the vice president of corporate development, the company announced this week.


Most recently, Brown was senior vice president of corporate development at Andrx. He also worked for 15 years with Bristol-Myers Squibb, where his experience included leading its corporate development function for the US. Brown holds a BS in chemistry from NeumannCollege.

Daniel Von Hoff has been appointed to the scientific advisory board of Halozyme Therapeutics, the company said this week. Von Hoff is currently a professor of medicine, pathology, and molecular and cellular biology at Arizona Health Sciences Center. He is also head of the Translational Genomics Research Institute's Translational Drug Development division.

CytRx announced last week that Marvin Selter has been named vice chairman of the company's board of directors. Selter has been on the board since Oct. 2003, and serves as the chairman of CytRx's audit committee. Selter is currently president of CMS, a national management consulting firm.

The Genetic Policy Institute announced this week the addition of seven new scientists to its scientific advisory board. The new scientific advisors include:

  • Genevieve Ames, adjunct professor at the Universityof California, Berkeley's Schoolof Public Health
  • Elizabeth Blackburn, professor of biochemistry and biophysics at the Universityof California, San Francisco
  • John Gearhart, professor of medicine at the Institute of Cell Engineering at Johns Hopkins University; professor of gynecology and obstetrics, physiology, and comparative medicine at Johns Hopkins' School of Medicine; and professor of biochemistry and molecular biology at Johns Hopkins' Bloomberg School of Public Health
  • Shin-Yong Moon, director of assisted reproductive technology and genetics laboratories at SeoulNationalUniversity
  • Roger Pederson, professor of regenerative medicine at the Universityof Cambridge
  • Evan Snyder, professor and program director of the Stem Cells and Regenerations program of the Burnham Institute.
  • Leon Zon, Howard Hughes Medical Institute investigator at Children's Hopsital and professor of pediatric medicine at Howard Medical School
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.